Empowering Patients in Clinical Research

At Richmond Pharmacology, we believe that clinical trials should be driven by the needs and experiences of the people who matter most – you, the patients.

That’s why we are fully committed to Patient and Public Involvement (PPI) in everything we do.

Through PPI, we involve patients, caregivers, and the public in reviewing clinical trial materials and providing feedback on trial designs and procedures. Your input ensures that our trials are patient-centred, accessible, and more reflective of real-world needs.

Why PPI Is Important to Us

Icon depicting efficiency

Patient-Focused Design

Your insights help shape how our clinical trials are structured, making sure they are as patient-friendly as possible.

icon depicting waste reduction

Clarity and Accessibility

We want all patient-facing documents, like Participant Information Sheets (PIS) and Informed Consent Forms (ICF), to be clear and easy to follow. Your feedback helps us achieve that.

icon depicting carbon neutrality. plant circling the earth

Collaborative Improvement

Together, we can create a better trial experience for you and future patients.

Get Involved in Our PPI Initiatives

We are inviting you to play an active role in shaping the future of clinical research. Whether you want to participate in focus groups or provide feedback on trial documents, your voice will make a difference.

Help us ensure that clinical trials put patients first. Together, we can make a lasting impact on the future of healthcare.

Join Our Focus Groups – Your Voice Can Make a Difference!

We’re looking for people interested in shaping the future of clinical trials. If you'd like to join our Patient and Public Involvement (PPI) focus groups at Richmond Pharmacology, please complete the form below. We value your insights and experiences to make clinical trials more patient-friendly and accessible.

Please complete all sections to register your interest
Upon submission, your interest will be shared with our team. If selected, we will contact you with further details about upcoming focus groups and next steps.Thank you for your interest in helping us improve clinical trials!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event